Predicting Human Tumor Response by 31 Mrs

Charles, Hal Cecil

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project--Cooperative Agreements (U01)
• Project #: 5U01CA062554-02
• Application #: 2103871
• Study Section: Special Emphasis Panel (SRC (S1))
• Project Start: 1995-07-21
• Project End: 2000-02-29
• Budget Start: 1996-03-01
• Budget End: 1997-02-28
• Support Year: 2
• Fiscal Year: 1996

Institution

• Name: Duke University
• Department: Radiation-Diagnostic/Oncology
• Type: Schools of Medicine
• DUNS #: 071723621
• City: Durham
• State: NC
• Country: United States
• Zip Code: 27705

Publications

Arias-Mendoza, F; Payne, G S; Zakian, K L et al. (2006) In vivo 31P MR spectral patterns and reproducibility in cancer patients studied in a multi-institutional trial. NMR Biomed 19:504-12

Arias-Mendoza, F; Zakian, K; Schwartz, A et al. (2004) Methodological standardization for a multi-institutional in vivo trial of localized 31P MR spectroscopy in human cancer research. In vitro and normal volunteer studies. NMR Biomed 17:382-91

Griffiths, J R; Tate, A R; Howe, F A et al. (2002) Magnetic Resonance Spectroscopy of cancer-practicalities of multi-centre trials and early results in non-Hodgkin's lymphoma. Eur J Cancer 38:2085-93